These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 15486196

  • 1. Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists.
    Soriano JV, Liu N, Gao Y, Yao ZJ, Ishibashi T, Underhill C, Burke TR, Bottaro DP.
    Mol Cancer Ther; 2004 Oct; 3(10):1289-99. PubMed ID: 15486196
    [Abstract] [Full Text] [Related]

  • 2. Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions.
    Atabey N, Gao Y, Yao ZJ, Breckenridge D, Soon L, Soriano JV, Burke TR, Bottaro DP.
    J Biol Chem; 2001 Apr 27; 276(17):14308-14. PubMed ID: 11278639
    [Abstract] [Full Text] [Related]

  • 3. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.
    Vacca A, Ribatti D, Iurlaro M, Albini A, Minischetti M, Bussolino F, Pellegrino A, Ria R, Rusnati M, Presta M, Vincenti V, Persico MG, Dammacco F.
    Int J Clin Lab Res; 1998 Apr 27; 28(1):55-68. PubMed ID: 9594364
    [Abstract] [Full Text] [Related]

  • 4. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM, Mc Entire J, Pallini R, Vakana E, Wyss L, Blosser W, Ricci-Vitiani L, D'Alessandris QG, Morgante L, Giannetti S, Larocca LM, Todaro M, Benfante A, Colorito ML, Stassi G, De Maria R, Rowlinson S, Stancato L.
    PLoS One; 2015 Apr 27; 10(4):e0125697. PubMed ID: 25919028
    [Abstract] [Full Text] [Related]

  • 5. The Role of Grb2 in Cancer and Peptides as Grb2 Antagonists.
    Ijaz M, Wang F, Shahbaz M, Jiang W, Fathy AH, Nesa EU.
    Protein Pept Lett; 2018 Feb 08; 24(12):1084-1095. PubMed ID: 29173143
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC, Scicli GM, McMahon G, Scicli AG.
    Microvasc Res; 2002 May 08; 63(3):304-15. PubMed ID: 11969307
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
    Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    Oncol Rep; 2005 Oct 08; 14(4):807-15. PubMed ID: 16142336
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways.
    Fretz H, Furet P, Garcia-Echeverria C, Schoepfer J, Rahuel J.
    Curr Pharm Des; 2000 Dec 08; 6(18):1777-96. PubMed ID: 11102562
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
    Kwak HJ, Park MJ, Park CM, Moon SI, Yoo DH, Lee HC, Lee SH, Kim MS, Lee HW, Shin WS, Park IC, Rhee CH, Hong SI.
    Int J Cancer; 2006 Jun 01; 118(11):2711-20. PubMed ID: 16388516
    [Abstract] [Full Text] [Related]

  • 13. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.
    Klint P, Kanda S, Kloog Y, Claesson-Welsh L.
    Oncogene; 1999 Jun 03; 18(22):3354-64. PubMed ID: 10362356
    [Abstract] [Full Text] [Related]

  • 14. A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis.
    Rouet V, Hamma-Kourbali Y, Petit E, Panagopoulou P, Katsoris P, Barritault D, Caruelle JP, Courty J.
    J Biol Chem; 2005 Sep 23; 280(38):32792-800. PubMed ID: 16014624
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Virally activated Ras cooperates with integrin to induce tubulogenesis in sinusoidal endothelial cell lines.
    Maru Y, Yamaguchi S, Takahashi T, Ueno H, Shibuya M.
    J Cell Physiol; 1998 Aug 23; 176(2):223-34. PubMed ID: 9648910
    [Abstract] [Full Text] [Related]

  • 17. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
    Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L, Boudouresque F.
    Int J Cancer; 2004 Mar 01; 108(6):797-804. PubMed ID: 14712479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade.
    Huang SM, Li J, Harari PM.
    Mol Cancer Ther; 2002 May 01; 1(7):507-14. PubMed ID: 12479268
    [Abstract] [Full Text] [Related]

  • 20. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH, Peng HC, Yang RS, Huang TF.
    Mol Pharmacol; 2001 May 01; 59(5):1333-42. PubMed ID: 11306719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.